DaPuMicro’s Shanghai GEM IPO: Pricing, Investor Risks, and Regulatory Gaps Revealed
DaPuMicro’s 2026 GEM IPO shows how a 20.9× price‑to‑sales multiple and heavy institutional allocation can mask deep losses and conflict‑of‑interest risks, urging stricter disclosure and valuation scrutiny.
5 minutes to read





